Effects of remote online exercise training in individuals with COVID-19 disease.

Not Applicable

Completed

• Conditions: Dyspnea; Fatigue; Anxiety; Depression; balance problem; decrease in functional mobility; COVID-19; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12622000121763
• Lead Sponsor: GÜLSAH BARGI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-25
• Study Completion: 2022-02-28
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Adult individuals aged 18 and over who volunteered to participate in the research
• Individuals who can understand and answer surveys
• Compatible individuals who can perform exercises and have good cooperation.
• Individuals have technology such as smart phone or computer, ipad, laptop etc. where surveys and exercises can be applied.
• Individuals with a positive Polymerase Chain Reaction (PCR) test result
• Individuals who are compatible with COVID-19 infection as a result of chest X-ray or lung tomography, although the PCR test result is negative.
• Individuals diagnosed with COVID-19 and self-isolating at home and following up for recovery

Exclusion Criteria

• Individuals with unstable angina pectoris, uncompensated heart failure, myocardial infarction in the past month, uncontrolled diabetes, hypertension above 180/110 mmHg, and/or severe neuropathy which may pose a risk during exercise practices
• Individuals diagnosed with COVID-19 and recovered by self-isolation at home
• Pregnant women
• Individuals with serious psychiatric illness and therefore unable to adapt to exercise sessions
• Individuals with severe cognitive impairment
• Individuals with ongoing orthopedic, neurological, cardiovascular disorders and/or problems which are independent of COVID-19
• Individuals with severe muscle spasm, involuntary weight loss, symptom inconsistency
• Individuals with severe dyspnea at rest and/or minimal effort, cyanosis, and/or hemoptysis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety score evaluated using Hospital anxiety and Depression Scale (0-21)[Baseline, at 4 weeks after baseline evaluation];Depression score evaluated using Hospital anxiety and Depression Scale (0-21)[Baseline, at 4 weeks after baseline evaluation]

Secondary Outcome Measures

Name	Time	Method
Dyspnea perception evaluated using Medical Research Council Dyspnea Scale (0-4)[Baseline, at 4 weeks after baseline evaluation];Fatigue score evaluated using Modified Borg scale (0-10)[Baseline, at every session, at 4 weeks after baseline evaluation];Effort intensity evaluated using Modified Borg Scale (0-10)[Baseline, at every session, at 4 weeks after baseline evaluation];Chronic fatigue level evaluated using Checklist Individual Strength Questionnaire[Baseline, at 4 weeks after baseline evaluation];Balance score evaluated using Berg Balance Scale (0-56)[Baseline, at 4 weeks after baseline evaluation];Functional mobility score evaluated using Chair Stand Test[Baseline, at 4 weeks after baseline evaluation]